FDA seeks more data on Novartis' meningitis vaccine Menveo

07/1/2009 | Reuters

Novartis said the FDA asked for more data on the clinical and the Chemistry Manufacturing and Control sections of its application for meningitis vaccine Menveo. The drugmaker said it might be able to fully address the concerns this year because the FDA did not recommend additional clinical trials.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX